KIMBERLY FARMER: Open Payments
NPI 1851395198 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 13 payments from 11 companies in 2025. Trend: 2023 $888 · 2024 $338 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: CAPLYTA, JARDIANCE, FREESTYLE LIBRE 3, MOUNJARO, PREVNAR 20, VRAYLAR, NEXLETOL, SHINGRIX.
Industry payments across NC — which companies pay providers there.
